nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—UGT1A1—Propofol—epilepsy syndrome	0.272	1	CbGbCtD
Raltegravir—CCR1—medulla oblongata—epilepsy syndrome	0.00391	0.177	CbGeAlD
Raltegravir—CCR1—midbrain—epilepsy syndrome	0.00358	0.162	CbGeAlD
Raltegravir—CCR1—spinal cord—epilepsy syndrome	0.00349	0.158	CbGeAlD
Raltegravir—CCR1—head—epilepsy syndrome	0.0031	0.14	CbGeAlD
Raltegravir—CCR1—nervous system—epilepsy syndrome	0.00294	0.133	CbGeAlD
Raltegravir—CCR1—central nervous system—epilepsy syndrome	0.00283	0.128	CbGeAlD
Raltegravir—CCR1—brain—epilepsy syndrome	0.00225	0.102	CbGeAlD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	0.000286	0.00109	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ACKR4—epilepsy syndrome	0.000284	0.00109	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—POMC—epilepsy syndrome	0.000281	0.00107	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—GNAO1—epilepsy syndrome	0.000281	0.00107	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—OPRD1—epilepsy syndrome	0.000281	0.00107	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	0.00028	0.00107	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—TXNRD1—epilepsy syndrome	0.00028	0.00107	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—GAL—epilepsy syndrome	0.000278	0.00107	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—GRM5—epilepsy syndrome	0.000275	0.00105	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CHRM3—epilepsy syndrome	0.000275	0.00105	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CHRM1—epilepsy syndrome	0.000269	0.00103	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PDYN—epilepsy syndrome	0.000269	0.00103	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—GRM1—epilepsy syndrome	0.000269	0.00103	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCR7—epilepsy syndrome	0.000269	0.00103	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	0.000265	0.00102	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CHRM2—epilepsy syndrome	0.000259	0.00099	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—BDKRB1—epilepsy syndrome	0.000259	0.00099	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SSTR5—epilepsy syndrome	0.000257	0.000984	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SSTR4—epilepsy syndrome	0.000257	0.000984	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—AVP—epilepsy syndrome	0.000256	0.000979	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—GAL—epilepsy syndrome	0.000253	0.000967	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—GABBR1—epilepsy syndrome	0.000252	0.000963	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CHRM3—epilepsy syndrome	0.00025	0.000956	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—GRM5—epilepsy syndrome	0.00025	0.000956	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCR10—epilepsy syndrome	0.000247	0.000943	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—HRH3—epilepsy syndrome	0.000241	0.000924	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CX3CR1—epilepsy syndrome	0.00024	0.000917	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—OPRM1—epilepsy syndrome	0.000238	0.000909	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—ABCC2—epilepsy syndrome	0.000235	0.0009	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—BDKRB1—epilepsy syndrome	0.000235	0.000899	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CHRM2—epilepsy syndrome	0.000235	0.000899	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CX3CL1—epilepsy syndrome	0.000235	0.000899	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—GABBR1—epilepsy syndrome	0.000229	0.000875	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CCR3—epilepsy syndrome	0.000224	0.000859	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	0.000223	0.000854	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—HRH3—epilepsy syndrome	0.000219	0.000839	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—SLC6A1—epilepsy syndrome	0.000219	0.000837	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—NPY—epilepsy syndrome	0.000219	0.000837	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	0.000219	0.000836	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CCR5—epilepsy syndrome	0.000218	0.000832	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—OPRM1—epilepsy syndrome	0.000216	0.000826	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GRM2—epilepsy syndrome	0.000216	0.000824	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—HTR2A—epilepsy syndrome	0.000213	0.000815	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CXCL2—epilepsy syndrome	0.000211	0.000807	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CRH—epilepsy syndrome	0.000211	0.000807	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—OXT—epilepsy syndrome	0.000211	0.000807	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCR3—epilepsy syndrome	0.000204	0.00078	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—AGT—epilepsy syndrome	0.000202	0.000773	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—NPY—epilepsy syndrome	0.000199	0.00076	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SSTR3—epilepsy syndrome	0.000195	0.000746	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CXCL2—epilepsy syndrome	0.000192	0.000733	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—OXT—epilepsy syndrome	0.000192	0.000733	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCL3—epilepsy syndrome	0.000192	0.000733	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CRH—epilepsy syndrome	0.000192	0.000733	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CCR2—epilepsy syndrome	0.000191	0.00073	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—SST—epilepsy syndrome	0.000191	0.00073	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000191	0.00073	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000187	0.000715	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—NPY2R—epilepsy syndrome	0.000187	0.000715	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCR8—epilepsy syndrome	0.000187	0.000715	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCR9—epilepsy syndrome	0.000187	0.000715	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SSTR1—epilepsy syndrome	0.000187	0.000715	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000187	0.000714	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GRM4—epilepsy syndrome	0.000183	0.000701	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GRM3—epilepsy syndrome	0.000183	0.000701	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SSTR2—epilepsy syndrome	0.00018	0.000688	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—DUSP4—epilepsy syndrome	0.00018	0.000688	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.000179	0.000686	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.000179	0.000686	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CNR1—epilepsy syndrome	0.000176	0.000674	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.000176	0.000671	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—SLC6A4—epilepsy syndrome	0.000175	0.000669	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GRM8—epilepsy syndrome	0.000174	0.000664	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PGF—epilepsy syndrome	0.000174	0.000664	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—SST—epilepsy syndrome	0.000173	0.000663	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCR2—epilepsy syndrome	0.000173	0.000663	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000172	0.000657	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—CYP2C19—epilepsy syndrome	0.000171	0.000654	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—POMC—epilepsy syndrome	0.00017	0.000651	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—CYP11A1—epilepsy syndrome	0.00017	0.00065	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.00017	0.000649	CbGpPWpGaD
Raltegravir—UGT1A1—Metapathway biotransformation—CYP2C19—epilepsy syndrome	0.000169	0.000645	CbGpPWpGaD
Raltegravir—UGT1A1—Metapathway biotransformation—CYP11A1—epilepsy syndrome	0.000168	0.000641	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CCL2—epilepsy syndrome	0.000166	0.000637	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—OPRD1—epilepsy syndrome	0.000166	0.000634	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GNAO1—epilepsy syndrome	0.000166	0.000634	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—AKT3—epilepsy syndrome	0.000164	0.000626	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000163	0.000623	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000163	0.000623	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—epilepsy syndrome	0.00016	0.000613	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CNR1—epilepsy syndrome	0.00016	0.000612	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000159	0.00061	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PDYN—epilepsy syndrome	0.000159	0.000608	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCR7—epilepsy syndrome	0.000159	0.000608	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CHRM1—epilepsy syndrome	0.000159	0.000608	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GRM1—epilepsy syndrome	0.000159	0.000608	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—SLC2A1—epilepsy syndrome	0.000158	0.000605	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—HTR7—epilepsy syndrome	0.000156	0.000597	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—epilepsy syndrome	0.000155	0.000594	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—CYP2D6—epilepsy syndrome	0.000153	0.000587	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—HBEGF—epilepsy syndrome	0.000152	0.000579	CbGpPWpGaD
Raltegravir—UGT1A1—Metapathway biotransformation—CYP2D6—epilepsy syndrome	0.000151	0.000579	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000149	0.000571	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GFAP—epilepsy syndrome	0.000149	0.000571	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GAL—epilepsy syndrome	0.000149	0.000571	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—HBEGF—epilepsy syndrome	0.000149	0.000569	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—AKT3—epilepsy syndrome	0.000149	0.000569	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GRM5—epilepsy syndrome	0.000148	0.000565	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CASP2—epilepsy syndrome	0.000148	0.000565	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CHRM3—epilepsy syndrome	0.000148	0.000565	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—AVP—epilepsy syndrome	0.000145	0.000553	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000142	0.000542	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—SRC—epilepsy syndrome	0.000139	0.000533	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000139	0.000531	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000139	0.000531	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CHRM2—epilepsy syndrome	0.000139	0.000531	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CDC42—epilepsy syndrome	0.000136	0.000519	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GABBR1—epilepsy syndrome	0.000135	0.000517	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—AVP—epilepsy syndrome	0.000131	0.000502	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—HMOX1—epilepsy syndrome	0.00013	0.000498	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—HRH3—epilepsy syndrome	0.00013	0.000495	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—OPRM1—epilepsy syndrome	0.000128	0.000488	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CCR5—epilepsy syndrome	0.000123	0.00047	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCR3—epilepsy syndrome	0.00012	0.000461	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—HTR2A—epilepsy syndrome	0.00012	0.00046	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ATP2A2—epilepsy syndrome	0.000117	0.000449	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—NPY—epilepsy syndrome	0.000117	0.000449	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CA13—epilepsy syndrome	0.000117	0.000448	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	0.000116	0.000445	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—AGT—epilepsy syndrome	0.000114	0.000437	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—HSPB1—epilepsy syndrome	0.000113	0.000433	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCL3—epilepsy syndrome	0.000113	0.000433	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CRH—epilepsy syndrome	0.000113	0.000433	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—OXT—epilepsy syndrome	0.000113	0.000433	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CXCL2—epilepsy syndrome	0.000113	0.000433	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCR5—epilepsy syndrome	0.000112	0.000427	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—HTR2A—epilepsy syndrome	0.000109	0.000418	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—PRKCB—epilepsy syndrome	0.000106	0.000404	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TSC1—epilepsy syndrome	0.000105	0.000403	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PTK2B—epilepsy syndrome	0.000105	0.000403	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—AGT—epilepsy syndrome	0.000104	0.000397	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCR2—epilepsy syndrome	0.000102	0.000392	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SST—epilepsy syndrome	0.000102	0.000392	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—NTRK2—epilepsy syndrome	0.000102	0.000392	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—DUSP6—epilepsy syndrome	0.000101	0.000388	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ADRA2A—epilepsy syndrome	0.0001	0.000383	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PLAT—epilepsy syndrome	9.98e-05	0.000382	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—BDKRB2—epilepsy syndrome	9.63e-05	0.000368	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CXCL12—epilepsy syndrome	9.63e-05	0.000368	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—POMC—epilepsy syndrome	9.61e-05	0.000368	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PRKCB—epilepsy syndrome	9.58e-05	0.000367	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—IL6ST—epilepsy syndrome	9.54e-05	0.000365	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—JUNB—epilepsy syndrome	9.45e-05	0.000361	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CNR1—epilepsy syndrome	9.45e-05	0.000361	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PLCB1—epilepsy syndrome	9.42e-05	0.00036	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—HTR7—epilepsy syndrome	9.22e-05	0.000353	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—HBEGF—epilepsy syndrome	8.95e-05	0.000342	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—FAR1—epilepsy syndrome	8.87e-05	0.000339	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GLUD1—epilepsy syndrome	8.87e-05	0.000339	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—L2HGDH—epilepsy syndrome	8.87e-05	0.000339	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CERS1—epilepsy syndrome	8.87e-05	0.000339	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PDXK—epilepsy syndrome	8.87e-05	0.000339	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ADK—epilepsy syndrome	8.87e-05	0.000339	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—AKT3—epilepsy syndrome	8.79e-05	0.000336	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—POMC—epilepsy syndrome	8.73e-05	0.000334	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ADAM10—epilepsy syndrome	8.58e-05	0.000328	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCL2—epilepsy syndrome	8.54e-05	0.000327	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—S100B—epilepsy syndrome	8.11e-05	0.00031	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GAMT—epilepsy syndrome	8.11e-05	0.00031	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—EPM2A—epilepsy syndrome	8.11e-05	0.00031	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PNPO—epilepsy syndrome	8.11e-05	0.00031	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—NHLRC1—epilepsy syndrome	8.11e-05	0.00031	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SOCS3—epilepsy syndrome	8.03e-05	0.000307	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CDC42—epilepsy syndrome	8.02e-05	0.000307	CbGpPWpGaD
Raltegravir—Asthenia—Oxcarbazepine—epilepsy syndrome	7.99e-05	0.00018	CcSEcCtD
Raltegravir—Pruritus—Clonazepam—epilepsy syndrome	7.98e-05	0.000179	CcSEcCtD
Raltegravir—Vomiting—Vigabatrin—epilepsy syndrome	7.97e-05	0.000179	CcSEcCtD
Raltegravir—Skin disorder—Valproic Acid—epilepsy syndrome	7.97e-05	0.000179	CcSEcCtD
Raltegravir—Urinary tract disorder—Topiramate—epilepsy syndrome	7.96e-05	0.000179	CcSEcCtD
Raltegravir—Oedema peripheral—Topiramate—epilepsy syndrome	7.94e-05	0.000179	CcSEcCtD
Raltegravir—Hyperhidrosis—Valproic Acid—epilepsy syndrome	7.94e-05	0.000179	CcSEcCtD
Raltegravir—Cough—Pregabalin—epilepsy syndrome	7.93e-05	0.000179	CcSEcCtD
Raltegravir—Pruritus—Phenytoin—epilepsy syndrome	7.92e-05	0.000178	CcSEcCtD
Raltegravir—Connective tissue disorder—Topiramate—epilepsy syndrome	7.92e-05	0.000178	CcSEcCtD
Raltegravir—Nausea—Levetiracetam—epilepsy syndrome	7.92e-05	0.000178	CcSEcCtD
Raltegravir—Rash—Vigabatrin—epilepsy syndrome	7.91e-05	0.000178	CcSEcCtD
Raltegravir—Dizziness—Felbamate—epilepsy syndrome	7.9e-05	0.000178	CcSEcCtD
Raltegravir—Dermatitis—Vigabatrin—epilepsy syndrome	7.9e-05	0.000178	CcSEcCtD
Raltegravir—Urethral disorder—Topiramate—epilepsy syndrome	7.9e-05	0.000178	CcSEcCtD
Raltegravir—Pruritus—Oxcarbazepine—epilepsy syndrome	7.88e-05	0.000177	CcSEcCtD
Raltegravir—Hypersensitivity—Carbamazepine—epilepsy syndrome	7.87e-05	0.000177	CcSEcCtD
Raltegravir—Headache—Vigabatrin—epilepsy syndrome	7.86e-05	0.000177	CcSEcCtD
Raltegravir—Hypertension—Pregabalin—epilepsy syndrome	7.85e-05	0.000177	CcSEcCtD
Raltegravir—Vomiting—Diazepam—epilepsy syndrome	7.85e-05	0.000177	CcSEcCtD
Raltegravir—Tremor—Gabapentin—epilepsy syndrome	7.81e-05	0.000176	CcSEcCtD
Raltegravir—Rash—Diazepam—epilepsy syndrome	7.78e-05	0.000175	CcSEcCtD
Raltegravir—Dermatitis—Diazepam—epilepsy syndrome	7.78e-05	0.000175	CcSEcCtD
Raltegravir—Visual impairment—Topiramate—epilepsy syndrome	7.77e-05	0.000175	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—AVP—epilepsy syndrome	7.76e-05	0.000297	CbGpPWpGaD
Raltegravir—Myalgia—Pregabalin—epilepsy syndrome	7.74e-05	0.000174	CcSEcCtD
Raltegravir—Chest pain—Pregabalin—epilepsy syndrome	7.74e-05	0.000174	CcSEcCtD
Raltegravir—Arthralgia—Pregabalin—epilepsy syndrome	7.74e-05	0.000174	CcSEcCtD
Raltegravir—Ill-defined disorder—Gabapentin—epilepsy syndrome	7.74e-05	0.000174	CcSEcCtD
Raltegravir—Dizziness—Zonisamide—epilepsy syndrome	7.73e-05	0.000174	CcSEcCtD
Raltegravir—Headache—Diazepam—epilepsy syndrome	7.73e-05	0.000174	CcSEcCtD
Raltegravir—Anxiety—Pregabalin—epilepsy syndrome	7.71e-05	0.000174	CcSEcCtD
Raltegravir—Diarrhoea—Clonazepam—epilepsy syndrome	7.71e-05	0.000174	CcSEcCtD
Raltegravir—Anaemia—Gabapentin—epilepsy syndrome	7.71e-05	0.000173	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	7.69e-05	0.000173	CcSEcCtD
Raltegravir—Asthenia—Carbamazepine—epilepsy syndrome	7.67e-05	0.000173	CcSEcCtD
Raltegravir—Agitation—Gabapentin—epilepsy syndrome	7.66e-05	0.000172	CcSEcCtD
Raltegravir—Diarrhoea—Phenytoin—epilepsy syndrome	7.66e-05	0.000172	CcSEcCtD
Raltegravir—Discomfort—Pregabalin—epilepsy syndrome	7.65e-05	0.000172	CcSEcCtD
Raltegravir—Nausea—Fosphenytoin—epilepsy syndrome	7.64e-05	0.000172	CcSEcCtD
Raltegravir—Diarrhoea—Oxcarbazepine—epilepsy syndrome	7.62e-05	0.000172	CcSEcCtD
Raltegravir—Erythema multiforme—Topiramate—epilepsy syndrome	7.62e-05	0.000171	CcSEcCtD
Raltegravir—Hypersensitivity—Lamotrigine—epilepsy syndrome	7.61e-05	0.000171	CcSEcCtD
Raltegravir—Vomiting—Felbamate—epilepsy syndrome	7.6e-05	0.000171	CcSEcCtD
Raltegravir—Dry mouth—Pregabalin—epilepsy syndrome	7.57e-05	0.00017	CcSEcCtD
Raltegravir—Pruritus—Carbamazepine—epilepsy syndrome	7.56e-05	0.00017	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—QDPR—epilepsy syndrome	7.54e-05	0.000288	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CA4—epilepsy syndrome	7.54e-05	0.000288	CbGpPWpGaD
Raltegravir—Rash—Felbamate—epilepsy syndrome	7.53e-05	0.00017	CcSEcCtD
Raltegravir—Eye disorder—Topiramate—epilepsy syndrome	7.53e-05	0.000169	CcSEcCtD
Raltegravir—Dermatitis—Felbamate—epilepsy syndrome	7.53e-05	0.000169	CcSEcCtD
Raltegravir—Malaise—Gabapentin—epilepsy syndrome	7.52e-05	0.000169	CcSEcCtD
Raltegravir—UGT1A1—Biological oxidations—POMC—epilepsy syndrome	7.52e-05	0.000288	CbGpPWpGaD
Raltegravir—Tinnitus—Topiramate—epilepsy syndrome	7.51e-05	0.000169	CcSEcCtD
Raltegravir—Vertigo—Gabapentin—epilepsy syndrome	7.49e-05	0.000169	CcSEcCtD
Raltegravir—Headache—Felbamate—epilepsy syndrome	7.49e-05	0.000168	CcSEcCtD
Raltegravir—Confusional state—Pregabalin—epilepsy syndrome	7.48e-05	0.000168	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	7.48e-05	0.000168	CcSEcCtD
Raltegravir—Cardiac disorder—Topiramate—epilepsy syndrome	7.48e-05	0.000168	CcSEcCtD
Raltegravir—Dizziness—Clonazepam—epilepsy syndrome	7.45e-05	0.000168	CcSEcCtD
Raltegravir—Nausea—Vigabatrin—epilepsy syndrome	7.45e-05	0.000168	CcSEcCtD
Raltegravir—Vomiting—Zonisamide—epilepsy syndrome	7.44e-05	0.000167	CcSEcCtD
Raltegravir—Insomnia—Valproic Acid—epilepsy syndrome	7.42e-05	0.000167	CcSEcCtD
Raltegravir—Asthenia—Lamotrigine—epilepsy syndrome	7.41e-05	0.000167	CcSEcCtD
Raltegravir—Dizziness—Phenytoin—epilepsy syndrome	7.4e-05	0.000167	CcSEcCtD
Raltegravir—Rash—Zonisamide—epilepsy syndrome	7.37e-05	0.000166	CcSEcCtD
Raltegravir—Infection—Pregabalin—epilepsy syndrome	7.37e-05	0.000166	CcSEcCtD
Raltegravir—Paraesthesia—Valproic Acid—epilepsy syndrome	7.37e-05	0.000166	CcSEcCtD
Raltegravir—Palpitations—Gabapentin—epilepsy syndrome	7.37e-05	0.000166	CcSEcCtD
Raltegravir—Dermatitis—Zonisamide—epilepsy syndrome	7.37e-05	0.000166	CcSEcCtD
Raltegravir—Dizziness—Oxcarbazepine—epilepsy syndrome	7.37e-05	0.000166	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—HES1—epilepsy syndrome	7.34e-05	0.000281	CbGpPWpGaD
Raltegravir—Nausea—Diazepam—epilepsy syndrome	7.33e-05	0.000165	CcSEcCtD
Raltegravir—Headache—Zonisamide—epilepsy syndrome	7.33e-05	0.000165	CcSEcCtD
Raltegravir—Diarrhoea—Carbamazepine—epilepsy syndrome	7.31e-05	0.000165	CcSEcCtD
Raltegravir—Angiopathy—Topiramate—epilepsy syndrome	7.31e-05	0.000165	CcSEcCtD
Raltegravir—Pruritus—Lamotrigine—epilepsy syndrome	7.31e-05	0.000164	CcSEcCtD
Raltegravir—Somnolence—Valproic Acid—epilepsy syndrome	7.3e-05	0.000164	CcSEcCtD
Raltegravir—Immune system disorder—Topiramate—epilepsy syndrome	7.28e-05	0.000164	CcSEcCtD
Raltegravir—Nervous system disorder—Pregabalin—epilepsy syndrome	7.28e-05	0.000164	CcSEcCtD
Raltegravir—Cough—Gabapentin—epilepsy syndrome	7.28e-05	0.000164	CcSEcCtD
Raltegravir—Thrombocytopenia—Pregabalin—epilepsy syndrome	7.27e-05	0.000164	CcSEcCtD
Raltegravir—Mediastinal disorder—Topiramate—epilepsy syndrome	7.26e-05	0.000163	CcSEcCtD
Raltegravir—Chills—Topiramate—epilepsy syndrome	7.23e-05	0.000163	CcSEcCtD
Raltegravir—Dyspepsia—Valproic Acid—epilepsy syndrome	7.23e-05	0.000163	CcSEcCtD
Raltegravir—Skin disorder—Pregabalin—epilepsy syndrome	7.21e-05	0.000162	CcSEcCtD
Raltegravir—Hypertension—Gabapentin—epilepsy syndrome	7.2e-05	0.000162	CcSEcCtD
Raltegravir—Hyperhidrosis—Pregabalin—epilepsy syndrome	7.17e-05	0.000161	CcSEcCtD
Raltegravir—Vomiting—Clonazepam—epilepsy syndrome	7.17e-05	0.000161	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—FYN—epilepsy syndrome	7.14e-05	0.000273	CbGpPWpGaD
Raltegravir—Decreased appetite—Valproic Acid—epilepsy syndrome	7.14e-05	0.000161	CcSEcCtD
Raltegravir—Alopecia—Topiramate—epilepsy syndrome	7.12e-05	0.00016	CcSEcCtD
Raltegravir—Vomiting—Phenytoin—epilepsy syndrome	7.12e-05	0.00016	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—H2AFX—epilepsy syndrome	7.11e-05	0.000272	CbGpPWpGaD
Raltegravir—Rash—Clonazepam—epilepsy syndrome	7.11e-05	0.00016	CcSEcCtD
Raltegravir—Dermatitis—Clonazepam—epilepsy syndrome	7.1e-05	0.00016	CcSEcCtD
Raltegravir—Myalgia—Gabapentin—epilepsy syndrome	7.1e-05	0.00016	CcSEcCtD
Raltegravir—Chest pain—Gabapentin—epilepsy syndrome	7.1e-05	0.00016	CcSEcCtD
Raltegravir—Arthralgia—Gabapentin—epilepsy syndrome	7.1e-05	0.00016	CcSEcCtD
Raltegravir—Nausea—Felbamate—epilepsy syndrome	7.1e-05	0.00016	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—MEF2C—epilepsy syndrome	7.1e-05	0.000271	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—COX3—epilepsy syndrome	7.09e-05	0.000271	CbGpPWpGaD
Raltegravir—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	7.09e-05	0.000159	CcSEcCtD
Raltegravir—Vomiting—Oxcarbazepine—epilepsy syndrome	7.08e-05	0.000159	CcSEcCtD
Raltegravir—Fatigue—Valproic Acid—epilepsy syndrome	7.08e-05	0.000159	CcSEcCtD
Raltegravir—Anxiety—Gabapentin—epilepsy syndrome	7.07e-05	0.000159	CcSEcCtD
Raltegravir—Dizziness—Carbamazepine—epilepsy syndrome	7.07e-05	0.000159	CcSEcCtD
Raltegravir—Diarrhoea—Lamotrigine—epilepsy syndrome	7.07e-05	0.000159	CcSEcCtD
Raltegravir—Headache—Clonazepam—epilepsy syndrome	7.06e-05	0.000159	CcSEcCtD
Raltegravir—Rash—Phenytoin—epilepsy syndrome	7.06e-05	0.000159	CcSEcCtD
Raltegravir—Mental disorder—Topiramate—epilepsy syndrome	7.06e-05	0.000159	CcSEcCtD
Raltegravir—Dermatitis—Phenytoin—epilepsy syndrome	7.05e-05	0.000159	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	7.05e-05	0.000159	CcSEcCtD
Raltegravir—Rash—Oxcarbazepine—epilepsy syndrome	7.02e-05	0.000158	CcSEcCtD
Raltegravir—Pain—Valproic Acid—epilepsy syndrome	7.02e-05	0.000158	CcSEcCtD
Raltegravir—Constipation—Valproic Acid—epilepsy syndrome	7.02e-05	0.000158	CcSEcCtD
Raltegravir—Dermatitis—Oxcarbazepine—epilepsy syndrome	7.02e-05	0.000158	CcSEcCtD
Raltegravir—Headache—Phenytoin—epilepsy syndrome	7.01e-05	0.000158	CcSEcCtD
Raltegravir—Erythema—Topiramate—epilepsy syndrome	7.01e-05	0.000158	CcSEcCtD
Raltegravir—Malnutrition—Topiramate—epilepsy syndrome	7.01e-05	0.000158	CcSEcCtD
Raltegravir—Discomfort—Gabapentin—epilepsy syndrome	7.01e-05	0.000158	CcSEcCtD
Raltegravir—Headache—Oxcarbazepine—epilepsy syndrome	6.98e-05	0.000157	CcSEcCtD
Raltegravir—Nausea—Zonisamide—epilepsy syndrome	6.95e-05	0.000156	CcSEcCtD
Raltegravir—Dry mouth—Gabapentin—epilepsy syndrome	6.94e-05	0.000156	CcSEcCtD
Raltegravir—Flatulence—Topiramate—epilepsy syndrome	6.91e-05	0.000156	CcSEcCtD
Raltegravir—Dysgeusia—Topiramate—epilepsy syndrome	6.87e-05	0.000155	CcSEcCtD
Raltegravir—Confusional state—Gabapentin—epilepsy syndrome	6.86e-05	0.000154	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—YWHAZ—epilepsy syndrome	6.86e-05	0.000262	CbGpPWpGaD
Raltegravir—Dizziness—Lamotrigine—epilepsy syndrome	6.83e-05	0.000154	CcSEcCtD
Raltegravir—Nervousness—Topiramate—epilepsy syndrome	6.81e-05	0.000153	CcSEcCtD
Raltegravir—Vomiting—Carbamazepine—epilepsy syndrome	6.8e-05	0.000153	CcSEcCtD
Raltegravir—Back pain—Topiramate—epilepsy syndrome	6.79e-05	0.000153	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—NGF—epilepsy syndrome	6.78e-05	0.000259	CbGpPWpGaD
Raltegravir—Feeling abnormal—Valproic Acid—epilepsy syndrome	6.76e-05	0.000152	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	6.76e-05	0.000152	CcSEcCtD
Raltegravir—Infection—Gabapentin—epilepsy syndrome	6.76e-05	0.000152	CcSEcCtD
Raltegravir—Rash—Carbamazepine—epilepsy syndrome	6.74e-05	0.000152	CcSEcCtD
Raltegravir—Dermatitis—Carbamazepine—epilepsy syndrome	6.73e-05	0.000152	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—KCNB1—epilepsy syndrome	6.72e-05	0.000257	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SLCO1A2—epilepsy syndrome	6.72e-05	0.000257	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CACNA2D2—epilepsy syndrome	6.72e-05	0.000257	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PFKL—epilepsy syndrome	6.72e-05	0.000257	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SLC6A8—epilepsy syndrome	6.72e-05	0.000257	CbGpPWpGaD
Raltegravir—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	6.71e-05	0.000151	CcSEcCtD
Raltegravir—Insomnia—Pregabalin—epilepsy syndrome	6.71e-05	0.000151	CcSEcCtD
Raltegravir—Nausea—Clonazepam—epilepsy syndrome	6.7e-05	0.000151	CcSEcCtD
Raltegravir—Headache—Carbamazepine—epilepsy syndrome	6.7e-05	0.000151	CcSEcCtD
Raltegravir—Nervous system disorder—Gabapentin—epilepsy syndrome	6.67e-05	0.00015	CcSEcCtD
Raltegravir—Paraesthesia—Pregabalin—epilepsy syndrome	6.66e-05	0.00015	CcSEcCtD
Raltegravir—Thrombocytopenia—Gabapentin—epilepsy syndrome	6.66e-05	0.00015	CcSEcCtD
Raltegravir—Nausea—Phenytoin—epilepsy syndrome	6.65e-05	0.00015	CcSEcCtD
Raltegravir—Nausea—Oxcarbazepine—epilepsy syndrome	6.62e-05	0.000149	CcSEcCtD
Raltegravir—Skin disorder—Gabapentin—epilepsy syndrome	6.61e-05	0.000149	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CCR5—epilepsy syndrome	6.6e-05	0.000252	CbGpPWpGaD
Raltegravir—Somnolence—Pregabalin—epilepsy syndrome	6.6e-05	0.000148	CcSEcCtD
Raltegravir—Hyperhidrosis—Gabapentin—epilepsy syndrome	6.58e-05	0.000148	CcSEcCtD
Raltegravir—Tremor—Topiramate—epilepsy syndrome	6.57e-05	0.000148	CcSEcCtD
Raltegravir—Vomiting—Lamotrigine—epilepsy syndrome	6.57e-05	0.000148	CcSEcCtD
Raltegravir—Urticaria—Valproic Acid—epilepsy syndrome	6.52e-05	0.000147	CcSEcCtD
Raltegravir—Rash—Lamotrigine—epilepsy syndrome	6.51e-05	0.000147	CcSEcCtD
Raltegravir—Ill-defined disorder—Topiramate—epilepsy syndrome	6.51e-05	0.000146	CcSEcCtD
Raltegravir—Dermatitis—Lamotrigine—epilepsy syndrome	6.51e-05	0.000146	CcSEcCtD
Raltegravir—Abdominal pain—Valproic Acid—epilepsy syndrome	6.49e-05	0.000146	CcSEcCtD
Raltegravir—Body temperature increased—Valproic Acid—epilepsy syndrome	6.49e-05	0.000146	CcSEcCtD
Raltegravir—Anaemia—Topiramate—epilepsy syndrome	6.48e-05	0.000146	CcSEcCtD
Raltegravir—Headache—Lamotrigine—epilepsy syndrome	6.47e-05	0.000146	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—HTR2A—epilepsy syndrome	6.46e-05	0.000247	CbGpPWpGaD
Raltegravir—Decreased appetite—Pregabalin—epilepsy syndrome	6.45e-05	0.000145	CcSEcCtD
Raltegravir—Agitation—Topiramate—epilepsy syndrome	6.45e-05	0.000145	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	6.41e-05	0.000144	CcSEcCtD
Raltegravir—Fatigue—Pregabalin—epilepsy syndrome	6.4e-05	0.000144	CcSEcCtD
Raltegravir—Nausea—Carbamazepine—epilepsy syndrome	6.35e-05	0.000143	CcSEcCtD
Raltegravir—Constipation—Pregabalin—epilepsy syndrome	6.35e-05	0.000143	CcSEcCtD
Raltegravir—Pain—Pregabalin—epilepsy syndrome	6.35e-05	0.000143	CcSEcCtD
Raltegravir—Malaise—Topiramate—epilepsy syndrome	6.33e-05	0.000142	CcSEcCtD
Raltegravir—Vertigo—Topiramate—epilepsy syndrome	6.3e-05	0.000142	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	6.2e-05	0.00014	CcSEcCtD
Raltegravir—Palpitations—Topiramate—epilepsy syndrome	6.2e-05	0.00014	CcSEcCtD
Raltegravir—Insomnia—Gabapentin—epilepsy syndrome	6.15e-05	0.000139	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—UPB1—epilepsy syndrome	6.15e-05	0.000235	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—NEU1—epilepsy syndrome	6.15e-05	0.000235	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ATIC—epilepsy syndrome	6.15e-05	0.000235	CbGpPWpGaD
Raltegravir—Nausea—Lamotrigine—epilepsy syndrome	6.14e-05	0.000138	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—TSC2—epilepsy syndrome	6.13e-05	0.000235	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—AGT—epilepsy syndrome	6.13e-05	0.000234	CbGpPWpGaD
Raltegravir—Cough—Topiramate—epilepsy syndrome	6.12e-05	0.000138	CcSEcCtD
Raltegravir—Feeling abnormal—Pregabalin—epilepsy syndrome	6.12e-05	0.000138	CcSEcCtD
Raltegravir—Paraesthesia—Gabapentin—epilepsy syndrome	6.11e-05	0.000138	CcSEcCtD
Raltegravir—Gastrointestinal pain—Pregabalin—epilepsy syndrome	6.07e-05	0.000137	CcSEcCtD
Raltegravir—Hypertension—Topiramate—epilepsy syndrome	6.06e-05	0.000136	CcSEcCtD
Raltegravir—Somnolence—Gabapentin—epilepsy syndrome	6.05e-05	0.000136	CcSEcCtD
Raltegravir—Hypersensitivity—Valproic Acid—epilepsy syndrome	6.05e-05	0.000136	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—APOE—epilepsy syndrome	6e-05	0.00023	CbGpPWpGaD
Raltegravir—Dyspepsia—Gabapentin—epilepsy syndrome	5.99e-05	0.000135	CcSEcCtD
Raltegravir—Arthralgia—Topiramate—epilepsy syndrome	5.97e-05	0.000134	CcSEcCtD
Raltegravir—Chest pain—Topiramate—epilepsy syndrome	5.97e-05	0.000134	CcSEcCtD
Raltegravir—Myalgia—Topiramate—epilepsy syndrome	5.97e-05	0.000134	CcSEcCtD
Raltegravir—Anxiety—Topiramate—epilepsy syndrome	5.95e-05	0.000134	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	5.93e-05	0.000133	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—HSD17B4—epilepsy syndrome	5.92e-05	0.000226	CbGpPWpGaD
Raltegravir—Decreased appetite—Gabapentin—epilepsy syndrome	5.92e-05	0.000133	CcSEcCtD
Raltegravir—Discomfort—Topiramate—epilepsy syndrome	5.9e-05	0.000133	CcSEcCtD
Raltegravir—Urticaria—Pregabalin—epilepsy syndrome	5.9e-05	0.000133	CcSEcCtD
Raltegravir—Asthenia—Valproic Acid—epilepsy syndrome	5.89e-05	0.000133	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—KDR—epilepsy syndrome	5.88e-05	0.000225	CbGpPWpGaD
Raltegravir—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	5.87e-05	0.000132	CcSEcCtD
Raltegravir—Fatigue—Gabapentin—epilepsy syndrome	5.87e-05	0.000132	CcSEcCtD
Raltegravir—Body temperature increased—Pregabalin—epilepsy syndrome	5.87e-05	0.000132	CcSEcCtD
Raltegravir—Abdominal pain—Pregabalin—epilepsy syndrome	5.87e-05	0.000132	CcSEcCtD
Raltegravir—Dry mouth—Topiramate—epilepsy syndrome	5.84e-05	0.000131	CcSEcCtD
Raltegravir—Constipation—Gabapentin—epilepsy syndrome	5.82e-05	0.000131	CcSEcCtD
Raltegravir—Pain—Gabapentin—epilepsy syndrome	5.82e-05	0.000131	CcSEcCtD
Raltegravir—Pruritus—Valproic Acid—epilepsy syndrome	5.81e-05	0.000131	CcSEcCtD
Raltegravir—Confusional state—Topiramate—epilepsy syndrome	5.77e-05	0.00013	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—GBE1—epilepsy syndrome	5.72e-05	0.000219	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPP1R3C—epilepsy syndrome	5.72e-05	0.000219	CbGpPWpGaD
Raltegravir—Infection—Topiramate—epilepsy syndrome	5.69e-05	0.000128	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—PRKCB—epilepsy syndrome	5.66e-05	0.000217	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IL6ST—epilepsy syndrome	5.64e-05	0.000216	CbGpPWpGaD
Raltegravir—Diarrhoea—Valproic Acid—epilepsy syndrome	5.62e-05	0.000126	CcSEcCtD
Raltegravir—Nervous system disorder—Topiramate—epilepsy syndrome	5.61e-05	0.000126	CcSEcCtD
Raltegravir—Feeling abnormal—Gabapentin—epilepsy syndrome	5.61e-05	0.000126	CcSEcCtD
Raltegravir—Thrombocytopenia—Topiramate—epilepsy syndrome	5.61e-05	0.000126	CcSEcCtD
Raltegravir—Gastrointestinal pain—Gabapentin—epilepsy syndrome	5.56e-05	0.000125	CcSEcCtD
Raltegravir—Skin disorder—Topiramate—epilepsy syndrome	5.56e-05	0.000125	CcSEcCtD
Raltegravir—Hyperhidrosis—Topiramate—epilepsy syndrome	5.53e-05	0.000125	CcSEcCtD
Raltegravir—Hypersensitivity—Pregabalin—epilepsy syndrome	5.47e-05	0.000123	CcSEcCtD
Raltegravir—Dizziness—Valproic Acid—epilepsy syndrome	5.43e-05	0.000122	CcSEcCtD
Raltegravir—Urticaria—Gabapentin—epilepsy syndrome	5.41e-05	0.000122	CcSEcCtD
Raltegravir—Abdominal pain—Gabapentin—epilepsy syndrome	5.38e-05	0.000121	CcSEcCtD
Raltegravir—Body temperature increased—Gabapentin—epilepsy syndrome	5.38e-05	0.000121	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—ASAH1—epilepsy syndrome	5.37e-05	0.000206	CbGpPWpGaD
Raltegravir—Asthenia—Pregabalin—epilepsy syndrome	5.32e-05	0.00012	CcSEcCtD
Raltegravir—Pruritus—Pregabalin—epilepsy syndrome	5.25e-05	0.000118	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—STXBP1—epilepsy syndrome	5.23e-05	0.0002	CbGpPWpGaD
Raltegravir—Vomiting—Valproic Acid—epilepsy syndrome	5.22e-05	0.000117	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	5.22e-05	0.000117	CcSEcCtD
Raltegravir—Insomnia—Topiramate—epilepsy syndrome	5.18e-05	0.000117	CcSEcCtD
Raltegravir—Rash—Valproic Acid—epilepsy syndrome	5.18e-05	0.000116	CcSEcCtD
Raltegravir—Dermatitis—Valproic Acid—epilepsy syndrome	5.17e-05	0.000116	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—POMC—epilepsy syndrome	5.16e-05	0.000197	CbGpPWpGaD
Raltegravir—Headache—Valproic Acid—epilepsy syndrome	5.14e-05	0.000116	CcSEcCtD
Raltegravir—Paraesthesia—Topiramate—epilepsy syndrome	5.14e-05	0.000116	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—NT5E—epilepsy syndrome	5.09e-05	0.000195	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ALAD—epilepsy syndrome	5.09e-05	0.000195	CbGpPWpGaD
Raltegravir—Somnolence—Topiramate—epilepsy syndrome	5.09e-05	0.000115	CcSEcCtD
Raltegravir—Diarrhoea—Pregabalin—epilepsy syndrome	5.08e-05	0.000114	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CCL2—epilepsy syndrome	5.05e-05	0.000193	CbGpPWpGaD
Raltegravir—Dyspepsia—Topiramate—epilepsy syndrome	5.04e-05	0.000113	CcSEcCtD
Raltegravir—Hypersensitivity—Gabapentin—epilepsy syndrome	5.01e-05	0.000113	CcSEcCtD
Raltegravir—Decreased appetite—Topiramate—epilepsy syndrome	4.98e-05	0.000112	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.94e-05	0.000111	CcSEcCtD
Raltegravir—Fatigue—Topiramate—epilepsy syndrome	4.94e-05	0.000111	CcSEcCtD
Raltegravir—Dizziness—Pregabalin—epilepsy syndrome	4.91e-05	0.00011	CcSEcCtD
Raltegravir—Constipation—Topiramate—epilepsy syndrome	4.9e-05	0.00011	CcSEcCtD
Raltegravir—Pain—Topiramate—epilepsy syndrome	4.9e-05	0.00011	CcSEcCtD
Raltegravir—Asthenia—Gabapentin—epilepsy syndrome	4.88e-05	0.00011	CcSEcCtD
Raltegravir—Nausea—Valproic Acid—epilepsy syndrome	4.88e-05	0.00011	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—ALDH7A1—epilepsy syndrome	4.86e-05	0.000186	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CACNA1A—epilepsy syndrome	4.86e-05	0.000186	CbGpPWpGaD
Raltegravir—Pruritus—Gabapentin—epilepsy syndrome	4.81e-05	0.000108	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—ST3GAL3—epilepsy syndrome	4.76e-05	0.000182	CbGpPWpGaD
Raltegravir—Vomiting—Pregabalin—epilepsy syndrome	4.72e-05	0.000106	CcSEcCtD
Raltegravir—Feeling abnormal—Topiramate—epilepsy syndrome	4.72e-05	0.000106	CcSEcCtD
Raltegravir—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.68e-05	0.000105	CcSEcCtD
Raltegravir—Rash—Pregabalin—epilepsy syndrome	4.68e-05	0.000105	CcSEcCtD
Raltegravir—Dermatitis—Pregabalin—epilepsy syndrome	4.67e-05	0.000105	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—ADSL—epilepsy syndrome	4.66e-05	0.000178	CbGpPWpGaD
Raltegravir—Diarrhoea—Gabapentin—epilepsy syndrome	4.66e-05	0.000105	CcSEcCtD
Raltegravir—Headache—Pregabalin—epilepsy syndrome	4.65e-05	0.000105	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—GLUL—epilepsy syndrome	4.57e-05	0.000175	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—FGF2—epilepsy syndrome	4.56e-05	0.000174	CbGpPWpGaD
Raltegravir—Urticaria—Topiramate—epilepsy syndrome	4.55e-05	0.000102	CcSEcCtD
Raltegravir—Body temperature increased—Topiramate—epilepsy syndrome	4.53e-05	0.000102	CcSEcCtD
Raltegravir—Abdominal pain—Topiramate—epilepsy syndrome	4.53e-05	0.000102	CcSEcCtD
Raltegravir—Dizziness—Gabapentin—epilepsy syndrome	4.5e-05	0.000101	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—CACNA1D—epilepsy syndrome	4.48e-05	0.000172	CbGpPWpGaD
Raltegravir—Nausea—Pregabalin—epilepsy syndrome	4.41e-05	9.92e-05	CcSEcCtD
Raltegravir—Vomiting—Gabapentin—epilepsy syndrome	4.33e-05	9.74e-05	CcSEcCtD
Raltegravir—Rash—Gabapentin—epilepsy syndrome	4.29e-05	9.66e-05	CcSEcCtD
Raltegravir—Dermatitis—Gabapentin—epilepsy syndrome	4.29e-05	9.65e-05	CcSEcCtD
Raltegravir—Headache—Gabapentin—epilepsy syndrome	4.26e-05	9.59e-05	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—RELA—epilepsy syndrome	4.23e-05	0.000162	CbGpPWpGaD
Raltegravir—Hypersensitivity—Topiramate—epilepsy syndrome	4.22e-05	9.49e-05	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—TXNRD1—epilepsy syndrome	4.19e-05	0.00016	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MTOR—epilepsy syndrome	4.15e-05	0.000159	CbGpPWpGaD
Raltegravir—Asthenia—Topiramate—epilepsy syndrome	4.11e-05	9.24e-05	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—AQP1—epilepsy syndrome	4.07e-05	0.000156	CbGpPWpGaD
Raltegravir—Pruritus—Topiramate—epilepsy syndrome	4.05e-05	9.12e-05	CcSEcCtD
Raltegravir—Nausea—Gabapentin—epilepsy syndrome	4.04e-05	9.1e-05	CcSEcCtD
Raltegravir—Diarrhoea—Topiramate—epilepsy syndrome	3.92e-05	8.82e-05	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.85e-05	0.000147	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CASP3—epilepsy syndrome	3.82e-05	0.000146	CbGpPWpGaD
Raltegravir—Dizziness—Topiramate—epilepsy syndrome	3.79e-05	8.52e-05	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—JUN—epilepsy syndrome	3.71e-05	0.000142	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CHRM3—epilepsy syndrome	3.68e-05	0.000141	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—KCNJ11—epilepsy syndrome	3.68e-05	0.000141	CbGpPWpGaD
Raltegravir—Vomiting—Topiramate—epilepsy syndrome	3.64e-05	8.19e-05	CcSEcCtD
Raltegravir—Rash—Topiramate—epilepsy syndrome	3.61e-05	8.12e-05	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—MMP9—epilepsy syndrome	3.61e-05	0.000138	CbGpPWpGaD
Raltegravir—Dermatitis—Topiramate—epilepsy syndrome	3.61e-05	8.12e-05	CcSEcCtD
Raltegravir—Headache—Topiramate—epilepsy syndrome	3.59e-05	8.07e-05	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—AKT1—epilepsy syndrome	3.5e-05	0.000134	CbGpPWpGaD
Raltegravir—Nausea—Topiramate—epilepsy syndrome	3.4e-05	7.65e-05	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—SRC—epilepsy syndrome	3.33e-05	0.000127	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—VEGFA—epilepsy syndrome	3.24e-05	0.000124	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ABCG2—epilepsy syndrome	3e-05	0.000115	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CYP2C19—epilepsy syndrome	2.93e-05	0.000112	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CYP11A1—epilepsy syndrome	2.91e-05	0.000111	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CYP2D6—epilepsy syndrome	2.62e-05	0.0001	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ADRA2A—epilepsy syndrome	2.5e-05	9.55e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—BCHE—epilepsy syndrome	2.49e-05	9.51e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SLC2A1—epilepsy syndrome	2.37e-05	9.08e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PLCB1—epilepsy syndrome	2.35e-05	8.98e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—TH—epilepsy syndrome	2.34e-05	8.95e-05	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—AKT1—epilepsy syndrome	2.07e-05	7.91e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HMOX1—epilepsy syndrome	1.95e-05	7.47e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CAT—epilepsy syndrome	1.93e-05	7.37e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ABCB1—epilepsy syndrome	1.87e-05	7.17e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GPX1—epilepsy syndrome	1.74e-05	6.66e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—AGT—epilepsy syndrome	1.53e-05	5.84e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOE—epilepsy syndrome	1.5e-05	5.72e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—POMC—epilepsy syndrome	1.29e-05	4.92e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ALB—epilepsy syndrome	1.17e-05	4.48e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PTGS2—epilepsy syndrome	1.03e-05	3.92e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—AKT1—epilepsy syndrome	5.15e-06	1.97e-05	CbGpPWpGaD
